PDS Biotechnology Stock (NASDAQ: PDSB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 944.308K |
Day Range | - - - |
52 Wk Range | 2.590 - 10.270 |
Market Cap | $127.644M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 19.36% |
Days to Cover | 11.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PDS Biotechnology (NASDAQ: PDSB) through any online brokerage.
Other companies in PDS Biotechnology’s space includes: Molecular Partners (NASDAQ:MOLN), Cellectar Biosciences (NASDAQ:CLRB), FibroGen (NASDAQ:FGEN), Vistagen Therapeutics (NASDAQ:VTGN) and Tevogen Bio Holdings (NASDAQ:TVGN).
The latest price target for PDS Biotechnology (NASDAQ: PDSB) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 21.00 expecting PDSB to rise to within 12 months (a possible 503.45% upside). 13 analyst firms have reported ratings in the last year.
The stock price for PDS Biotechnology (NASDAQ: PDSB) is $3.48 last updated May 20, 2024 at 9:10 AM EDT.
There are no upcoming dividends for PDS Biotechnology.
PDS Biotechnology’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for PDS Biotechnology.
PDS Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.